Dimed S.A. Distribuidora de Medicamentos EBIT

Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA) currently reports a EBIT of $280M as of June 2026. That compares with $260M in the prior-year period — up 7.9% year over year. That is below the sector sector average of $2.4T. Use the charts on this page to explore Dimed S.A. Distribuidora de Medicamentos's EBIT history and peer comparisons.

Dimed S.A. Distribuidora de Medicamentos's EBIT increased from $260M to $280M — a 7.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dimed S.A. Distribuidora de Medicamentos's EBIT of $280M is lower than the its sector sector average of $2.4T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Dimed S.A. Distribuidora de Medicamentos reported $280M in EBIT as of June 2026. That compares with $260M in the prior-year period — up 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.4T. From there, open related valuation or income-statement pages for Dimed S.A. Distribuidora de Medicamentos, and consider following PNVL3.SA for alerts when major investors trade the stock.